I 

114TH CONGRESS 

1ST SESSION H. R. 3676 

To authorize the Administrator of the Substance Abuse and Mental Health 

Services Administration, acting through the Director of the Center for 

Substance Abuse Treatment, to award grants to States to expand access 

to clinically appropriate services for opioid abuse, dependence, or addiction. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 1, 2015 

Mr. FOSTER (for himself, Ms. ESTY, Ms. EDWARDS, and Mr. SEAN PATRICK

MALONEY of New York) introduced the following bill; which was referred 

to the Committee on Energy and Commerce 

A BILL 

To authorize the Administrator of the Substance Abuse and 

Mental Health Services Administration, acting through 

the Director of the Center for Substance Abuse Treatment, to award grants to States to expand access to 

clinically appropriate services for opioid abuse, dependence, or addiction. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Expanding Opportuni5 ties for Recovery Act of 2015’’. 


smartinez on DSK4TPTVN1PROD with BILLS
2 

•HR 3676 IH

1 SEC. 2. OPIOID ADDICTION TREATMENT. 

2 (a) IN GENERAL.—The Administrator of the Sub3 stance Abuse and Mental Health Services Administration, 

4 acting through the Director of the Center for Substance 

5 Abuse Treatment (in this section referred to as the ‘‘Ad6 ministrator’’) shall award grants to States to expand ac7 cess to clinically appropriate services for opioid abuse, de8 pendence, or addiction. 

9 (b) REQUIREMENTS.—As conditions on the receipt of 

10 a grant under this section, a State shall agree to comply 

11 with the following: 

12 (1) The grant will be administered through the 

13 head of the State’s primary agency responsible for 

14 programs and activities relating to the treatment of 

15 substance abuse. 

16 (2) The services through the grant will be evi17 dence-based such as medication-assisted treatment 

18 for substance use disorder. 

19 (3) The services through the grant will be pro20 vided according to a physician or a clinician’s rec21 ommendation to ensure that individuals receive the 

22 optimal level of substance use disorder treatment for 

23 the amount of time that is deemed medically nec24 essary. 

25 (4) The services through the grant will be pro26 vided exclusively to individuals— 


smartinez on DSK4TPTVN1PROD with BILLS
3 

•HR 3676 IH

1 (A) who lack health insurance; or 

2 (B) whose health insurance— 

3 (i) does not cover such services; or 

4 (ii) places other barriers on the re5 ceipt of such services, such as— 

6 (I) limiting coverage of such serv7 ices to a certain period of time; or 

8 (II) imposing non-quantitative 

9 treatment limitations that are more 

10 stringent than treatment limitations 

11 imposed on other medical conditions 

12 (such as a requirement to use less ex13 pensive services, like out-patient treat14 ment, prior to more expensive, but 

15 physician-recommended services, such 

16 as in-patient or residential treatment). 

17 (5) The grant will not be used to pay or sub18 sidize the cost of more than 60 consecutive days of 

19 opioid abuse, dependence, or addiction treatment in 

20 the case of any individual. 

21 (c) PERMISSIBLE PROVISION OF MEDICATIONS.—In 

22 expanding access to clinically appropriate services for 

23 opioid abuse, dependence, or addiction through a grant 

24 under this section, a State may provide for the use of 


smartinez on DSK4TPTVN1PROD with BILLS
4 

•HR 3676 IH

1 medications, in conjunction with other treatment, so long 

2 as— 

3 (1) the medications are lawfully marketed 

4 under the Federal Food, Drug, and Cosmetic Act 

5 (21 U.S.C. 301 et seq.); 

6 (2) are clinically indicated to address the abuse, 

7 dependence, or addiction; and 

8 (3) are offered consistent with consumer choice. 

9 (d) COORDINATION.—The Administrator shall coordi10 nate the program under this section with the program for 

11 prevention and treatment of substance abuse under sub12 part II of part B of title XIX of the Public Health Service 

13 Act (42 U.S.C. 300x–21 et seq.). 

14 (e) EVALUATION; DISSEMINATION OF INFORMATION; 

15 TECHNICAL ASSISTANCE.— 

16 (1) IN GENERAL.—The Administrator shall— 

17 (A) require States receiving a grant under 

18 this section to report appropriate outcome 

19 measures associated with use of the grant, in20 cluding any— 

21 (i) decreases in substance use; 

22 (ii) changes in retention in care; 

23 (iii) connections to the next appro24 priate level of care; 


smartinez on DSK4TPTVN1PROD with BILLS
5 

•HR 3676 IH

1 (iv) decreases in involvement with 

2 criminal justice activities; and 

3 (v) other outcome data as appropriate; 

4 (B) require States receiving a grant under 

5 this section to report data on individuals’ length 

6 of time under clinically appropriate addiction 

7 treatment, and the use of medication-assisted 

8 treatment; 

9 (C) evaluate the activities supported by 

10 grants under this section; 

11 (D) submit to the Congress and the Sec12 retary, and make publicly available on the 

13 Internet site of the Substance Abuse and Men14 tal Health Services Administration, information 

15 about the results of such evaluation; and 

16 (E) offer technical assistance to States re17 ceiving a grant under this section regarding ac18 tivities funded through the grant. 

19 (2) USE OF CERTAIN FUNDS.—Of the funds ap20 propriated to carry out this section for any fiscal 

21 year, 5 percent shall be available to carry out activi22 ties under this subsection. 

Æ 


smartinez on DSK4TPTVN1PROD with BILLS